Antitrust agencies amend premerger notification rules to clarify reporting of certain acquisitions of exclusive patent rights in the pharmaceutical industry
By EsqSocial Corporation 14/11/13
The US Federal Trade Commission, with the concurrence of the Antitrust Division of the US Department of Justice, has amended the premerger notification rules to clarify when a transfer of exclusive rights to a patent or part of a patent in the...
By: DLA Piper